Cutaneous findings related to cardiovascular disorders

International Journal of Dermatology

Volumn 37, Issue 3, 1998, Pages 161-172

  George, William M ^a,b  

^a HAMAD MEDICAL CORPORATION   (Qatar)

^b NONE   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METOPROLOL; MEXILETINE; MINOXIDIL; PROCAINAMIDE; QUINIDINE; THIAZIDE DIURETIC AGENT; VERAPAMIL; WARFARIN;

ACROCYANOSIS; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; CARCINOID; CARDIOVASCULAR DISEASE; CHRONIC VEIN INSUFFICIENCY; CYANOSIS; DEVELOPMENTAL DISORDER; ERYTHROMELALGIA; FAT EMBOLISM; GRAFT VERSUS HOST REACTION; HEART SURGERY; HUMAN; KAPOSI SARCOMA; KELOID; MALIGNANT ATROPHIC PAPULOSIS; METABOLIC DISORDER; PERIPHERAL CIRCULATION; PIGMENT DISORDER; REVIEW; SARCOIDOSIS; SKIN DISCOLORATION; SKIN INFECTION; SKIN MANIFESTATION;

CARDIOVASCULAR DISEASES; HUMANS; SKIN DISEASES;

EID: 0031888599     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1998.00356.x     Document Type: Review

References (150)

1. Richter T, Hettmannsperger U. Idiopathic clubbing of the fingers. Pathogenetic mechanisms and differential etiologic diagnosis. Hautarzt 1994; 45: 866-870.
2. Chan HL. Cutaneous manifestations of cardiac diseases. Singapore Med J 1990; 31: 480-485.
3. Schraibman IG. Localized hirsuties. Postgrad Med J 1967; 43: 545-547.
4. de-Nicola P, Tassi G. Microcirculation in the conjunctiva and the nail bed in the aged. Symptomatic and clinico-pharmacologic aspects. Minerva Med 1981; 73: 32,251-32,362.
5. Arcasoy MM, Guntheroth WG, Smuckler E. Myocardial disease. A case associated with hyperpigmentation and multifocal vascular sclerosis. Am J Dis Child 1968; 116: 434-438.
6. Guevara L, Cesarman G. A 30-year-old woman with diabetes mellitus, generalized cutaneous hyperpigmentation and congestive heart failure (clinical conference). Rev Invest Clin 1986; 38: 429-433.
7. Urbach E. White cross striae of the finger nails following cardiac infarction. Arch Dermatol 1945; 52: 106-107.
8. Nomland R. Cutaneous manifestations of the circulatory disorders of the foot. JAMA 1944; 124: 747-750.
9. Carter JE Jr, Feldman T, Carroll JD. Sustained reversal of right to left atrial septal defect flow after pulmonic valvuloplasty in an adult. Eur Heart J 1994; 15: 575-576.
10. Osler W, Christian HA. Principles and Practice of Medicine, 15th edn. New York: Appleton-Century Co., Inc., 1944.
11. Niermeyer S, Yang P, Shanmina, et al. Arterial oxygen saturation in Tibetan and Han infants born in Lhasa, Tibet. N Engl J Med 1995; 333: 1248-1252.
12. Ryan TJ, Copeman PW. Microvascular pattern and blood stasis in skin disease. Br J Dermatol 1969; 81: 563-573.
13. Seckel H. Chronische Stauungshaut beim Linde. Monatschr Kinderh 1934; 45: 550-554.
14. Copeman PW, Ryan TJ. Cutaneous angiitis: patterns of rashes explained by (1) flow properties of blood; (2) anatomical disposition of vessels. Br J Dermatol 1971; 85: 205-214.
15. Yosipovitch G, Krause I, Blickstein D. Erythromelalgia in a patient with thrombotic thrombocytopenic purpura. J Am Acad Dermatol 1992; 26: 825-827.
16. Bauerschmitz J, Knop J. Cutaneous manifestations of essential thrombocythemia. Erythromelalgia, ischemic acrocyanosis, livedo racemosa. Hautarzt 1995; 46: 477-478.
17. Michiels JJ, van Joost T. Erythromelalgia and thrombocythemia: a causal relation. J Am Acad Dermatol 1990; 22: 107-111.
18. Michiels JJ, van Joost T, Vuzevski VD. Idiopathic erythermalgia: a congenital disorder. J Am Acad Dermatol 1989; 21: 1128-1130.
19. Sephel GC, Sturrock A, Giro MG, Davidson JM. Increased elastin production by progeria skin fibroblasts is controlled by the steady-state levels of elastin mRNA. J Invest Dermatol 1988; 90: 643-647.
20. Badame AJ. Progeria. Arch Dermatol 1989; 125: 540-544.
21. Gillar PJ, Kaye CI, McCourt JW. Progressive early dermatologic changes in Hutchinson-Gilford progeria syndrome. Pediatr Dermatol 1991; 8: 199-206.
22. Herman KL, Salman K, Rose LI. White forelock in Marfan's syndrome: an unusual association, with review of the literature. Cutis 1991; 48: 81-84.
23. Beaune J, Nony P, Chassignolle J, et al. Aortic insufficiency caused by dystrophic aneurysm of the ascending aorta: study of development in 95 cases. Value of cutaneous biopsy in the etiologic diagnosis. Arch Mal Coeur Vaiss 1989; 82: 1389-1396.
24. Nanko H, Jepsen LV, Zachariae H, Sogaard H. Acquired cutis laxa (generalized elastolysis): light and electron microscopic studies. Acta Derm Venereol 1979; 59: 315-324.
25. Mehregan AH, Lee SC, Nabai H. Cutis laxa (generalized elastolysis). A report of four cases with autopsy findings. J Cutan Pathol 1978; 5: 116-126.
26. Hayden JG, Talner NS, Klaus SN. Cutis laxa associated with pulmonary artery stenosis. J Pediatr 1968; 72: 506-509.
27. Prockop DJ, Kivirikko KI. Heritable diseases of collagen. N Engl J Med 1984; 311: 376-386.
28. Brandt KD, Sumner RD, Ryan TJ, Cohen A. Herniation of mitral leaflets in the Ehlers-Danlos syndrome. Am J Cardiol 1975; 36: 514-518.
29. Krivit W, Desnick RJ, Mapes C, et al. Recent advances in Fabry's disease. Trans Assoc Am Physicians 1970; 83: 121-132.
30. Wallace HJ. Anderson Fabry disease. Br J Dermatol 1973; 88: 1-23.
31. Hunt A. Tuberous sclerosis: a survey of 97 cases. II: Physical findings. Dev Med Child Neurol 1983; 25: 350-352.
32. Roach S, Delgado R. Tuberous sclerosis. Dermatol Clin 1995; 13: 151-161.
33. Obadia I, Fraga S, Benstein S, Souza Marques A. A case of Pringle-Bourneville disease with unusual aspects. An Bras Dermatol 1968; 43: 288-190.
34. Riccardi VM. Cutaneous manifestation of neurofibromatosis: cellular interaction, pigmentation, and mast cells. Birth Defects 1981; 17: 119-145.
35. Uren N, Been M, Guzman F. Congenital left atrial wall aneurysm in a patient with neurofibromatosis. Br Heart J 1988; 59: 391-394.
36. Quattrin T, McPherson E, Putnam T. Vertical transmission of the neurofibromatosis/Noonan syndrome. Am J Med Genet 1987; 26: 645-649.
37. Carcassi U, Passiu G. Collagenopathic cardiopathies. Ann Ital Med Int 1991; 6: 483-490.
38. Alexopoulos D, Christodoulou J, Cokkinos DV, Vagenakis AG. Accelerated coronary artery disease in a young woman with pseudoxanthoma, early atherosclerotic vascular elasticum and elevated lipoprotein(a). Eur Heart J 1994; 15: 1428-1430.
39. Korn S, Seilnacht J, Hutch C, Feller AM. Cardiovascular manifestations of pseudoxanthoma elasticum (Gronblad-Strandberg syndrome). Thorac Cardiovasc Surg 1987; 35: 191-194.
40. Bennis A, Mehadji BA, Soulami S, et al. Cardiovascular manifestations of hereditary dysplasia of connective tissue. Ann Cardiol Angeiol Paris 1993; 42: 173-181.
41. Cristol R, Debray J, Aron. Cardiovascular manifestations in pseudoxanthoma elasticum apropos of a typical case with myocardial infarction. Ann Med Intern Paris 1972; 113: 771-776.
42. Jurecka W, Gebhart W, Knobler R, et al. The leopard syndrome, a cardio-cutaneous syndrome. Wien Klin Wochenschr 1983; 95: 652-656.
43. Agha A, Hashimoto K. Multiple lentigines (Leopard) syndrome with Chiara I malformation. J Dermatol 1995; 22: 520-523.
44. Savage PJ. Cardiovascular complications of diabetes mellitus: what we know and what we need to know about their prevention. Ann Intern Med 1996; 124: 123-126.
45. Laakso M. Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus. Ann Intern Med 1996; 124: 127-130.
46. Goodfellow J, Ramsey MW, Luddington LA, et al. Endothelium and inelastic arteries: an early marker of vascular dysfunction in non-insulin-dependent diabetes. Br Med J 1996; 312: 744-745.
47. Kerl H. Pretibial pigmentation spots in diabetes mellitus (diabetic dermopathy). Z Haut Geschlechtskr 1971; 46: 619-624.
48. Kelly WF, Nicholas J, Adams J, Mahmood R. Necrobiosis lipoidica diabeticorum: association with background retinopathy, smoking, and proteinuria. A case controlled study. Diabet Med 1993; 10: 725-728.
49. Hata Y, Shigematsu H, Tsushima M, et al. Serum lipid and lipoprotein profiles in patients with xanthomas: a correlative study on xanthoma and atherosclerosis (I). Jpn Circ J 1981; 45: 1236-1242.
50. Hempstead RW, Chase WF. Skin changes in diabetic hand syndrome. J Assoc Military Dermat 1983; IX: 30-31.
51. Rosenbloom AL. Limited joint mobility in childhood diabetic mellitus indicates increased risk for microvascular disease. N Engl J Med 1981; 305: 191-194.
52. Ribera M, Pinto X, Argimon M, et al. Lipid metabolism and apolipoprotein E phenotypes in patients with xanthelasma. Am J Med 1995; 99: 485-490.
53. Roberts WC, Levy R, Fredrickson DS. Hyperlipoproteinemia: a review of the five types with first report of necropsy findings in type III. Arch Pathol 1970; 90: 46.
54. Denk R. Skin and cardiovascular system. Internist Berl 1974; 15: 192-200.
55. Brownstein MH, Helwig EB. The cutaneous amyloidoses. II. Systemic forms. Arch Dermatol 1970; 102: 8-19.
56. Klunemann H, Schneider J, Linke RP, et al. Fatal generalized AA amyloidosis in mutilating psoriatic arthropathy. Pathologie 1994; 15: 366-371.
57. Guevara L, Cesarman G. A 30-year-old woman with diabetes mellitus, generalized cutaneous hyperpigmentation and congestive heart failure (clinical conference). Rev Invest Clin 1986; 38: 419-433.
58. Demircin M, Dogan R, Peker O, et al. Aortic insufficiency and enterococcal endocarditis complicating systemic lupus erythematosus. Thorac Cardiovasc Surg 1995; 43: 302-304.
59. Frustaci A, Gentiloni N, Caldarulo M. Acute myocarditis and left ventricular aneurysm as presentations of systemic lupus erythematosus. Chest 1996; 109: 282-284.
60. Durand I, Blaysat G, Chauvaud S, et al. Extensive fibrous endocarditis as first manifestation of systemic lupus erythematosus. Arch Fr Pediatr 1993; 50: 685-688.
61. Atallah A, Hamousin Metregiste R, Samuel J, et al. Left ventricular thrombosis complicating systemic lupus erythematosus. Arch Mal Coeur Vaiss 1995; 88: 1043-1045.
62. Aiuto LT, Stambouly JJ, Boxer RA. Cardiac tamponade in an adolescent female: an unusual manifestation of systemic lupus erythematosus [letter]. Clin Pediatr Philadelphia 1993; 32: 566-567.
63. Cervera R, Font J, Pare C, et al. Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis 1992; 51: 156-159.
64. Ong ML, Veerapen K, Chambers JB, et al. Cardiac abnormalities in systemic lupus erythematosus: prevalence and relationship to disease activity. Int J Cardiol 1992; 34: 69-74.
65. Takayanagi K, Nakamura Y, Kishimoto M, et al. Cardiac rupture following acute myocardial infarction in systemic lupus erythematosus: case report. Angiology 1990; 41: 662-666.
66. Rudra T, Evans PA, O'Brien EN. Systemic lupus erythematosus presenting with cardiac tamponade due to a haemorrhagic pericardial effusion. Postgrad Med J 1987; 63: 567-568.
67. Barzizza F, Venco A, Grandi AM, Finardi G. Mitral valve prolapse in systemic lupus erythematosus. Clin Exp Rheumatol 1987; 5: 59-62.
68. Badui E, Garcia Rubi D, Robles E, et al. Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology 1985; 36: 431-441.
69. White PH. Pediatric systemic lupus erythematosus and neonatal lupus. Rheum Dis Clin North Am 1994; 20: 119-127.
70. Lee LA. Neonatal lupus erythematosus. J Invest Dermatol 1993; 100: 9S-13S.
71. Yale SH, Adlakha A, Stanton MS. Dermatomyositis with pericardial tamponade and polymyositis with pericardial effusion. Am Heart J 1993; 126: 997-999.
72. Chwalinska-Sadowska H, Maldykowa H. Polymyositis-dermatomyositis - a 2.5-year follow-up of 50 patients (analysis of clinical symptoms and signs and results of laboratory tests). Mater Med Pol 1990; 22: 205-212.
73. Lee P. Clinical aspects of systemic and localized sclerosis. Curr Opin Rheumatol 1993; 5: 785-791.
74. Montanes P, Lawless C, Black C, et al. The heart in scleroderma: noninvasive assessment. Clin Cardiol 1982; 5: 383-387.
75. McFadden N, Ree K, Soyland E, Larsen TE. Scleredema adultorum associated with a monoclonal gammopathy and generalized hyperpigmentation. Arch Dermatol 1987; 123: 629-632.
76. Livieri C, Monafo V, Bozzola M, Marni E. Buschke's scleredema and carditis: a clinical case. Pediatr Med Chir 1982; 4: 695-697.
77. Claudy AL. Diagnosis of cutaneous vasculitis. Int Angiol 1995; 14: 183-187.
78. Palazzo E, Bourgeois P, Meyer O, et al. Hypocomplementemic urticarial vasculitis syndrome, Jaccoud's syndrome, valvulopathy: a new syndromic combination. J Rheumatol 1993; 20: 1236-1240.
79. Dovzhanskii SI, Sherstneva VN, Kozbeva VI, et al. A case of generalized herpes zoster ending fatally. Vestn Dermatol Venerol 1990; 11: 48-49.
80. Stollerman GH. Rheumatic carditis. Lancet 1995; 346: 390-392.
81. Yee J, McAllister CK. Osler's nodes and the recognition of infective endocarditis: a lesion of diagnostic importance. South Med J 1987; 80: 753-757.
82. Rubenfeld S, Min KW. Leukocytoclastic angiitis in subacute bacterial endocarditis. Arch Dermatol 1977; 113: 1073-1074.
83. Azevedo J, Ribeiro C, Loureiro O, Cordeiro A. Rheumatic symptoms and signs in subacute infective endocarditis. Eur Heart J 1984; 5(Suppl. C): 71-75.
84. Oteo Revuelta JA, Martinez de Artola V, Gomez Cadinanos R, et al. Erythema chronicum migrans (Lyme's disease). Clinico-epidemiologic study of 10 cases. Rev Clin Esp 1993; 193: 20-23.
85. Maestre JR, Almagro M, Martinez P, et al. Localized scleroderma (morphea) and septic arthritis. Clinical manifestations of Lyme borreliosis seen in El Ferrol. Enferm Infect Microbiol Clin 1991; 9: 394-398.
86. Guerrero A, Quereda C, Escudero R, et al. Serologic diagnosis of Lyme disease. A pending problem. Enferm Infect Microbiol Clin 1991; 9: 335-338.
87. Berner E, Moncada X, Aris H, Sazunic I. Erythema chronicum migrans and Lyme's disease. Rev Med Chil 1989; 117: 1271-1274.
88. Milich MV. Case of a gumma of the heart. Vestn Dermatol Venerol 1980; 9: 69-71.
89. Suzuki A, Kamiya T, Kuwahara N, et al. Coronary arterial lesion of Kawasaki disease: cardiac catheterization findings of 1100 cases. Pediatr Cardiol 1986; 7: 3-9.
90. Lebranchu Y. Kawasaki disease. Treatment with intravenous gammaglobulins. Presse Med 1989; 18: 1147-1150.
91. Tizard EJ, Suzuki A, Levin M, Dillon MJ. Clinical aspects of 100 patients with Kawasaki disease. Arch Dis Child 1991; 66: 185-188.
92. Bergfeldt L, Edhag O, Rajs J. HLA-B27-associated heart disease. Clinicopathologic study of three cases. Am J Med 1984; 77: 961-967.
93. Ribeiro P, Morley KD, Shapiro LM, et al. Left ventricular function in patients with ankylosing spondylitis and Reiter's disease. Eur Heart J 1984; 5: 419-422.
94. Cosh JA, Barritt DW, Jayson MI. Cardiac lesions of Reiter's syndrome and ankylosing spondylitis. Br Heart J 1973; 35: 553.
95. Saari R, Lahti R, Saari KM, et al. Frequency of rheumatic diseases in patients with acute anterior uveitis. Scand J Rheumatol 1982; 11: 121-123.
96. Horan DB, Redman F, Jansen GT. Papulosquamous lesions of glans penis. Urology 1984; 23: 1-4.
97. Jalava S, Paljarvi L, Isomaki H. Keratodermia blenorrhagica, arthritis, and polymyositis with cardiopulmonary complications. Ann Rheum Dis 1983; 42: 455-459.
98. Williams HC, Du Vivier AW. Etretinate and AIDS-related Reiter's disease. Br J Dermatol 1991; 124: 389-392.
99. Davio P, Casagranda I, Moroni M, et al. The diagnostic difficulties in a case of Behcet's disease. Recenti Prog Med 1993; 84: 850-854.
100. Bosch JA, Montalban J, Vilardell M. Neuro-Behcet. Rev Clin Esp 1994; 194: 623-628.
101. Kabbaj N, Benjelloun G, Gueddari FZ, et al. Vascular involvements in Behcet disease. Based on 40 patient records. J Radiol 1993; 74: 649-656.
102. Sawai N, Okada T, Sato R, et al. A case of Behcet disease with coronary aneurysm, aortic valve insufficiency, and abdominal aortic aneurysm. Nippon Naika Gakkai Zasshi 1993; 82: 1105-1106.
103. Kawakami Y, Nakayama Y, Nagao H, et al. A case of Behcet's disease complicated with acute myocardial infarction. Kokyu To Junkan 1991; 39: 935-938.
104. Murakami CS, Odland PB, Ross BK. Buffered local anesthetics and epinephrine degradation. J Dermatol Surg Oncol 1994; 20: 192-195.
105. Stewart JH, Chinn SE, Cole GW, Klein JA. Neutralized lidocaine with epinephrine for local anesthesia - II. J Dermatol Surg Oncol 1990; 16: 842-845.
106. Fulton JE Jr. Silicone gel sheeting for the prevention and management of evolving hypertrophic and keloid scars. Dermatol Surg 1995; 21: 947-951.
107. Chinnock R, Emery J, Larsen R, et al. Methotrexate therapy for complex graft rejection in pediatric heart transplant recipients. J Heart Lung Transplant 1995; 14: 726-733.
108. Hull RJ, Bray RA, Hillyer C, Swerlick RA. Transfusion-associated chronic cutaneous graft-versus-host disease. J Am Acad Dermatol 1995; 33: 327-332.
109. Ammann AJ. New insight into the causes of immunodeficiency disorders. J Am Acad Dermatol 1984; 11: 653-660.
110. Sola MA, Espana A, Redondo P, et al. Transfusion-associated acute graft-versus-host disease in a heart transplant recipient. Br J Dermatol 1995; 132: 626-630.
111. Rosansky SJ, Deschamps EG. Multiple cholesterol emboli syndrome after angiography. Am Med Sci 1984; 288: 45-48.
112. Otsubo H, Kaito K, Takahashi H, et al. Cholesterol emboli following percutaneous transluminal coronary angioplasty as speculated by toe skin biopsy. Intern Med 1995; 34: 134-137.
113. Brown NJ, Morgan HJ. Spontaneous cholesterol emboli presenting as livedo reticularis. J Tenn Med Assoc 1992; 85: 64.
114. Park S, Schroeter AL, Park YS, Fortson J. Purple toes and livedo reticularis in a patient with cardiovascular disease taking coumadin. Cholesterol emboli associated with coumadin therapy. Arch Dermatol 1993; 129: 777, 780.
115. Kalter DC, Rudolph A, McGavran M. Livedo reticularis due to multiple cholesterol emboli. J Am Acad Dermatol 1985; 13: 235-242.
116. Deschamps P, Leroy D, Mandard JC. Cutaneous crystal cholesterol emboli. Acta Derm Venereol 1980; 60: 266-269.
117. Philit F, Mornex JF, Dureau G, et al. Cutaneous Kaposi's sarcoma with pulmonary carcinomatous lymphangitis in patient with heart transplantation. Rev Mal Respir 1994; 11: 421-423.
118. Krause M, Frei D, Rudlinger R, et al. Kaposi's sarcoma following kidney transplantation: remission following reduction of immunosuppression and consequent HIV infection. Schweiz Med Wochenschr 1988; 23: 118: 100-105.
119. Stratton MA. Drug-induced systemic lupus erythematosus. Clin Pharm 1985; 4: 657-663.
120. Akle CA, Joiner CL. Purple toe syndrome. J R Soc Med 1981; 74: 219.
121. Staubli M, Zimmermann A, Bircher J. Amiodarone-induced vasculitis and polyserositis. Postgrad Med J 1985; 61: 245-247.
122. Jackson RV, Williamson MM, Seneviratne B, Gordon RD. Long term minoxidil therapy and renal function, cardiac function, hypertrichosis and blood pressure. Aust N Z J Med 1983; 13: 39-44.
123. Ackerman BH, Townsend ME, Golden W, Bryan AB. Pruritic rash with actinic keratosis and impending exfoliation in a patient with hypertension managed with minoxidil. Drug Intell Clin Pharm 1988; 21: 702-703.
124. Schurer NY, Lehmann P, Plewig G. Quinidine-induced photoallergy. A clinical and experimental study. Hautarzt 1991; 42: 158-161.
125. Gold MH, Holy AK, Roenigk HH Jr. Beta-blocking drugs and psoriasis. A review of cutaneous side effects and retrospective analysis of their effects on psoriasis. J Am Acad Dermatol 1988; 19: 837-841.
126. Krikorian RK, Quick A, Tal A. Angioedema following the intravenous administration of metoprolol. Chest 1994; 106: 1921-1923.
127. Maier C. Life-threatening postoperative angioedema following treatment with an angiotensin converting enzyme inhibitor. Anaesthetist 1995; 44: 875-879.
128. Bishop PC, Wisnieski JJ, Christensen J. Recurrent angioedema and urticaria. West J Med 1993; 159: 605-608.
129. Drenth JP, Michiels JJ, Van Joost T, Vuzevski VD. Verapamil-induced secondary erythermalgia. Br J Dermatol 1992; 127: 292-294.
130. Yamazaki S, Katayama I, Kurumaji Y, et al. Contact urticaria induced by mexiletine hydrochloride in a patient receiving iontophoresis [letter]. Br J Dermatol 1994; 130: 538-540.
131. Habot B, Rabinovitz C, Friedensohn A, et al. A severe skin reaction following mexiletene. Harefuah 1992; 123: 462, 506.
132. Seggev JS, Lagstein Z. Photosensitivity skin reactions to calcium channel blockers. J Allergy Clin Immunol 1996; 97: 852-855.
133. Wakelin SH, James MP. Diltiazem induced acute generalised exanthematous pustulosis. Clin Exp Dermatol 1995; 20: 341-344.
134. Krasovec M, Ricci C, Frenk E. A case from practice (327). Acute generalized exanthematous pustulosis induced by diltiazem. Schweiz Rundsch Med Prax 1995; 84: 814-816.
135. Wirebaugh SR, Geraets DR. Reports of erythematous macular skin eruptions associated with diltiazem therapy. Drug Intel Clin Pharmacol 1990; 24: 1046-1049.
136. Meyboom RH, de Jonge K, Veentjer H, et al. Potentiation of digoxin by itraconazole. Ned Tijdschr Geneeskd 1994; 138: 2353-2356.
137. Thompson D, Oster G. Use of terfenadine and contraindicated drugs. JAMA 1996; 275: 1339-1341.
138. Pierce RN, Smith GJ. Intrathoracic manifestations of Degos' disease (malignant atrophic papulosis). Chest 1978; 73: 79-84.
139. De Leo G, Losacco T, Punzo C, et al. Report of a case of malignant atrophic papulosis or Degos disease. G Chir 1994; 15: 97-102.
140. Fleming HA. Cardiac sarcoidosis. Clin Dermatol 1986; 4: 143-149.
141. Lanfranchi J, Battesti JP, Marland P, Bersay C. Conduction disorders during cardiac sarcoidosis (author's transi.). Poumon Coeur 1979; 35: 247-252.
142. Smith AG, Greaves MW. Blood prostaglandin activity associated with noradrenaline-provoked flush in the carcinoid syndrome. Br J Dermatol 1974; 90: 547-551.
143. Stretton TB, Holmes AM, Horrocks P. Carcinoid heart disease without cutaneous flushing. Br Heart J 1968; 30: 285-287.
144. Frank ST. Aural sign of coronary artery disease. N Engl J Med 1973; 289: 834.
145. Shoenfield Y, Mor R, Weinberger A, et al. Diagonal ear lobe crease and coronary risk factors. J Am Geriatr Soc 1980; 27: 184.
146. Christiansen JS, Mathiesen B, Andresen AR, et al. Diagonal ear lobe crease in coronary heart disease. N Engl J Med 1975; 293: 308.
147. Doering C, Ruhsenberger C, Philips DS. Ear lobe crease in heart disease. J Am Geriatr Soc 1977; 25: 183.
148. Sternlieb JJ, Gau GT, Davis GD, et al. The ear crease sign in coronary artery disease. Circulation 1974; 50(Suppl. III): 152.
149. Elliott WJ, Powell LH. Diagonal earlobe creases and prognosis in patients with suspected coronary artery disease. Am J Med 1996; 100: 205-211.
150. Cumberland GD, Riddick L, Vinson R. Earlobe creases and coronary atherosclerosis. The view from forensic pathology. Am J Forensic Med Pathol 1987; 8: 9-11.